S100A7 and lip and oral cavity carcinoma: Patients with overexpression of cytoplasmic S100A7 showed reduced oral cancer-free survival (OCFS) of 68.6 months when compared to patients with weak or no S100A7 expression in immunostaining in the cytoplasm (mean OCFS = 122.8 months) [95].